CN103405725B - 一种治疗乳腺增生的以海洋药物为主的中药组合物 - Google Patents
一种治疗乳腺增生的以海洋药物为主的中药组合物 Download PDFInfo
- Publication number
- CN103405725B CN103405725B CN201310377352.4A CN201310377352A CN103405725B CN 103405725 B CN103405725 B CN 103405725B CN 201310377352 A CN201310377352 A CN 201310377352A CN 103405725 B CN103405725 B CN 103405725B
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- volatile oil
- chinese medicine
- sargassum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 86
- 239000000203 mixture Substances 0.000 title claims abstract description 50
- 229940079593 drug Drugs 0.000 title claims abstract description 30
- 241000195474 Sargassum Species 0.000 claims abstract description 26
- 239000002671 adjuvant Substances 0.000 claims abstract description 8
- 239000000341 volatile oil Substances 0.000 claims description 35
- 235000019640 taste Nutrition 0.000 claims description 25
- 238000002360 preparation method Methods 0.000 claims description 24
- 239000000706 filtrate Substances 0.000 claims description 14
- 239000008187 granular material Substances 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 239000006187 pill Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 7
- 238000003809 water extraction Methods 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- 229930195725 Mannitol Natural products 0.000 claims description 3
- 239000000594 mannitol Substances 0.000 claims description 3
- 235000010355 mannitol Nutrition 0.000 claims description 3
- 238000001291 vacuum drying Methods 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 108010011485 Aspartame Proteins 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- 206010013786 Dry skin Diseases 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 239000000605 aspartame Substances 0.000 claims description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 2
- 235000010357 aspartame Nutrition 0.000 claims description 2
- 229960003438 aspartame Drugs 0.000 claims description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 229960001855 mannitol Drugs 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 229940083542 sodium Drugs 0.000 claims description 2
- 235000015424 sodium Nutrition 0.000 claims description 2
- 238000005507 spraying Methods 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 229940013618 stevioside Drugs 0.000 claims description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 2
- 235000019202 steviosides Nutrition 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 229960004793 sucrose Drugs 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 20
- 210000004369 blood Anatomy 0.000 abstract description 19
- 241000721047 Danaus plexippus Species 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 208000002193 Pain Diseases 0.000 description 18
- 210000000481 breast Anatomy 0.000 description 14
- 210000004185 liver Anatomy 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 201000010099 disease Diseases 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 5
- 230000005906 menstruation Effects 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010018498 Goitre Diseases 0.000 description 3
- 206010022998 Irritability Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 201000003872 goiter Diseases 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- OPFTUNCRGUEPRZ-QLFBSQMISA-N (-)-beta-elemene Chemical compound CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000000260 Warts Diseases 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000005075 mammary gland Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 229930182490 saponin Chemical class 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 201000010153 skin papilloma Diseases 0.000 description 2
- OPFTUNCRGUEPRZ-UHFFFAOYSA-N (+)-beta-Elemen Natural products CC(=C)C1CCC(C)(C=C)C(C(C)=C)C1 OPFTUNCRGUEPRZ-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010006223 Breast discharge Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- QRMPRVXWPCLVNI-UHFFFAOYSA-N Curcumenol Natural products C1C(=C)C2CCC(C)C22CC(C(C)C)C1(O)O2 QRMPRVXWPCLVNI-UHFFFAOYSA-N 0.000 description 1
- ZVMJXSJCBLRAPD-ZFWWWQNUSA-N Curzerenone Chemical group C1[C@@](C=C)(C)[C@@H](C(=C)C)C(=O)C2=C1OC=C2C ZVMJXSJCBLRAPD-ZFWWWQNUSA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- ZVMJXSJCBLRAPD-UHFFFAOYSA-N Epicurzerenone Natural products C1C(C=C)(C)C(C(=C)C)C(=O)C2=C1OC=C2C ZVMJXSJCBLRAPD-UHFFFAOYSA-N 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 239000005717 Laminarin Substances 0.000 description 1
- 229920001543 Laminarin Polymers 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- -1 Phenylpropanoid Glycosides Chemical class 0.000 description 1
- 206010065347 Premenstrual pain Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 208000030270 breast disease Diseases 0.000 description 1
- 159000000007 calcium salts Chemical group 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- ISFMXVMWEWLJGJ-NZBPQXDJSA-N curcumenol Chemical compound CC1=C[C@](O2)(O)C(=C(C)C)C[C@@]22[C@@H](C)CC[C@H]21 ISFMXVMWEWLJGJ-NZBPQXDJSA-N 0.000 description 1
- QUQIBYMETMROHZ-UHFFFAOYSA-N curzerenone Natural products CCC1(C)Cc2occ(C)c2C(=O)C1C(C)C QUQIBYMETMROHZ-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 125000000567 diterpene group Chemical group 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 229930009674 sesquiterpene lactone Natural products 0.000 description 1
- 150000002107 sesquiterpene lactone derivatives Chemical group 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310377352.4A CN103405725B (zh) | 2013-08-27 | 2013-08-27 | 一种治疗乳腺增生的以海洋药物为主的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310377352.4A CN103405725B (zh) | 2013-08-27 | 2013-08-27 | 一种治疗乳腺增生的以海洋药物为主的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103405725A CN103405725A (zh) | 2013-11-27 |
CN103405725B true CN103405725B (zh) | 2015-09-09 |
Family
ID=49598798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310377352.4A Expired - Fee Related CN103405725B (zh) | 2013-08-27 | 2013-08-27 | 一种治疗乳腺增生的以海洋药物为主的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103405725B (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1742979A (zh) * | 2005-09-21 | 2006-03-08 | 灵宝市商业医院 | 一种治疗乳腺增生的中药 |
CN1857670A (zh) * | 2006-03-21 | 2006-11-08 | 吉林省中医中药研究院 | 一种用于治疗乳腺增生的药物及其制备方法 |
CN1970064A (zh) * | 2006-11-30 | 2007-05-30 | 灵宝市商业医院 | 治疗乳腺增生的药物 |
CN101129527A (zh) * | 2007-08-23 | 2008-02-27 | 王培凤 | 治疗乳腺疾病的药物 |
CN102233116A (zh) * | 2010-04-28 | 2011-11-09 | 成都中医药大学 | 治疗乳腺增生的药物组合物及其制备方法 |
-
2013
- 2013-08-27 CN CN201310377352.4A patent/CN103405725B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1742979A (zh) * | 2005-09-21 | 2006-03-08 | 灵宝市商业医院 | 一种治疗乳腺增生的中药 |
CN1857670A (zh) * | 2006-03-21 | 2006-11-08 | 吉林省中医中药研究院 | 一种用于治疗乳腺增生的药物及其制备方法 |
CN1970064A (zh) * | 2006-11-30 | 2007-05-30 | 灵宝市商业医院 | 治疗乳腺增生的药物 |
CN101129527A (zh) * | 2007-08-23 | 2008-02-27 | 王培凤 | 治疗乳腺疾病的药物 |
CN102233116A (zh) * | 2010-04-28 | 2011-11-09 | 成都中医药大学 | 治疗乳腺增生的药物组合物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
"乳腺增生病中药用药规律分析";孙杨;《山东中医杂志》;20120831;第31卷(第8期);544-546 * |
"消瘿五海丸加减治疗乳腺小叶增生64 例小结";刘德录;《湖南中医杂志》;19940930;第10卷(第5期);63 * |
Also Published As
Publication number | Publication date |
---|---|
CN103405725A (zh) | 2013-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101234164B (zh) | 改善皮肤油水平衡与痤疮症状的药物组合物及其制备方法 | |
CN102362950A (zh) | 一种治疗白癜风的中药 | |
CN104784673A (zh) | 一种用于小儿腹泻的中药脐贴 | |
CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
CN101897933B (zh) | 一种治疗白癜风的中成药 | |
CN102430097A (zh) | 一种治疗白癜风的中药 | |
CN102579677B (zh) | 一种治疗脑胶质瘤的中药组合物 | |
CN101700390B (zh) | 一种内服治疗脂肪肝的中药组合物 | |
CN103920114A (zh) | 一种治疗肺纤维化的中药组合物 | |
CN103041233A (zh) | 一种治疗小儿腹泻的药物组合物及其制备方法 | |
CN103405725B (zh) | 一种治疗乳腺增生的以海洋药物为主的中药组合物 | |
CN102406893A (zh) | 一种治疗银屑病的中成药 | |
CN105999092A (zh) | 一种治疗结肠黑变病的中药药丸 | |
CN104306847A (zh) | 一种六味补气胶囊及其制备工艺 | |
CN104288581A (zh) | 用于治疗先兆流产的中药 | |
CN103520378B (zh) | 一种治疗脾虚气滞型慢性胃炎的中药制剂及制备方法 | |
CN101095922A (zh) | 一种治疗糖尿病性末梢神经炎的中药组合物 | |
CN103330911B (zh) | 治疗冠心病的中药组合物粉剂及其制备方法 | |
CN102091163A (zh) | 一种治疗糖尿病性心脏病的中药组合物 | |
CN102205067A (zh) | 一种治疗慢性荨麻疹的中药组合物 | |
CN101085318A (zh) | 一种治疗肾病综合征的中药 | |
CN105381410A (zh) | 一种治疗肝炎的中药制剂 | |
CN103301303A (zh) | 一种治疗糖尿病的中药组合物 | |
CN104189693A (zh) | 一种治疗绝经后骨质疏松症的中药组合物 | |
CN103536883B (zh) | 治疗心肾气阴两虚证型虚劳病的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHANDONG UNIVERSITY Free format text: FORMER OWNER: SHOUGUANG FUKANG PHARMACEUTICAL CO., LTD. Effective date: 20150212 Owner name: SHOUGUANG FUKANG PHARMACEUTICAL CO., LTD. SHANDONG Free format text: FORMER OWNER: SHANDONG FUKANG BIOLOGICAL TECHNOLOGY PRODUCTIVITY PROMOTION CENTER SHOUGUANG YONGKANG CHEMICAL INDUSTRY CO., LTD. Effective date: 20150212 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Tao Inventor after: Xing Chengguo Inventor after: PETER.PROULX Inventor after: Song Chenggang Inventor after: Lin Wenhan Inventor after: Gao Dongsheng Inventor after: Gao Yan Inventor after: Liu Wenfeng Inventor after: Li Hongcheng Inventor before: Song Weiguo Inventor before: Song Chenggang Inventor before: Lin Wenhan Inventor before: Gao Dongsheng Inventor before: Gao Yan Inventor before: Liu Wenfeng Inventor before: Li Hongcheng |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 262700 WEIFANG, SHANDONG PROVINCE TO: 250000 JINAN, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: SONG WEIGUO SONG CHENGGANG LIN WENHAN GAO DONGSHENG GAO YAN LIU WENFENG LI HONGCHENG TO: LI TAO XING CHENGGUO PETER PROULX SONG CHENGGANG LIN WENHAN GAO DONGSHENG GAO YAN LIU WENFENG LI HONGCHENG |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150212 Address after: 250000 No. 44, Wenhua West Road, Shandong, Ji'nan Applicant after: Shandong University Applicant after: Shouguang Fukang Pharmaceutical Co., Ltd. Applicant after: Shandong Fukang Biotechnology Productivity Promotion Center Address before: 262700 5, East Street, Shouguang college, Shandong Applicant before: Shouguang Fukang Pharmaceutical Co., Ltd. Applicant before: Shandong Fukang Biotechnology Productivity Promotion Center Applicant before: Shouguang Yongkang Chemical Industry Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150909 Termination date: 20160827 |